Canopy Growth Corp (CGC) — SEC Financial Statements & Analysis

Canopy Growth Corp (CGC) is a medicinal chemicals & botanical products company, incorporated in Z4. Canopy Growth Corp trades on Nasdaq as: CGC. Canopy Growth Corp (CGC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Canopy Growth Corp carries a market cap of $401.15M, a P/E ratio of -1.72x, a P/B ratio of 0.58x, a P/S ratio of 1.12x, an enterprise value of $304.73M, and an EV/EBITDA multiple of -2.15x. On profitability, it posts a gross margin of 20.61%, an operating margin of -44.96%, a net margin of -64.90%, a Return on Equity (ROE) of -39.91%, a Return on Assets (ROA) of -23.16%, and a Return on Invested Capital (ROIC) of -25.74%. Per share, it reports EPS of $-0.55, diluted EPS of $-0.55, free cash flow per share of $-0.20, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 9.64% year-over-year, net income growth of -45.47% year-over-year, and EPS growth of -75.68% year-over-year. On the balance sheet, it maintains a current ratio of 3.04x, a quick ratio of 2.30x, working capital of $339.61M, a debt-to-equity ratio of 0.60x, a debt ratio of 0.38, free cash flow of $-83.24M (TTM), and net debt of $-96.42M. Figures sourced from SEC EDGAR.

Market Cap

$401.15M

P/E TTM

-1.72x

EPS TTM

$-0.55

P/B TTM

0.58x

ROE TTM

-39.91%

ROA TTM

-23.16%

Debt To Equity

0.60x

Free Cash Flow TTM

$-83.24M

Net Revenue TTM Growth 1Y

9.64%

Data as of 2026-06-30 · Source: SEC EDGAR